--- title: "JINGXING PAPER: Net profit loss of 14.1724 million yuan in the third quarter, a decrease of 708.74%" type: "News" locale: "zh-CN" url: "https://longbridge.com/zh-CN/news/263498839.md" description: "JINGXING PAPER announced that its revenue for the third quarter was 1.568 billion yuan, a year-on-year increase of 14.01%; net profit was a loss of 14.1724 million yuan, a decrease of 708.74%. Revenue for the first three quarters was 4.197 billion yuan, a year-on-year increase of 3.64%; net profit was 40.8615 million yuan, a decrease of 18.33%" datetime: "2025-10-30T11:06:01.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/263498839.md) - [en](https://longbridge.com/en/news/263498839.md) - [zh-HK](https://longbridge.com/zh-HK/news/263498839.md) --- > 支持的语言: [English](https://longbridge.com/en/news/263498839.md) | [繁體中文](https://longbridge.com/zh-HK/news/263498839.md) # JINGXING PAPER: Net profit loss of 14.1724 million yuan in the third quarter, a decrease of 708.74% JINGXING PAPER announced that its revenue for the third quarter was 1.568 billion yuan, a year-on-year increase of 14.01%; the net profit loss was 14.1724 million yuan, a decrease of 708.74%. Revenue for the first three quarters was 4.197 billion yuan, a year-on-year increase of 3.64%; the net profit was 40.8615 million yuan, a decrease of 18.33% ### 相关股票 - [JINGXING PAPER (002067.CN)](https://longbridge.com/zh-CN/quote/002067.CN.md) ## 相关资讯与研究 - [How Canfor’s Q4 Losses and Pulp Delisting Plan Will Impact Canfor (TSX:CFP) Investors](https://longbridge.com/zh-CN/news/278275989.md) - [US to Relax Ship Rule in Bid to Ease Rising Fuel Prices](https://longbridge.com/zh-CN/news/278925336.md) - [Tajikistan Approves Hebei Changsha Biochemical Pharmaceutical's Thrombosis Injection](https://longbridge.com/zh-CN/news/278372421.md) - [Vox Royalty to Court Institutional Investors at Roth Growth Conference](https://longbridge.com/zh-CN/news/278572258.md) - [Three vessels hit by projectiles in Strait of Hormuz](https://longbridge.com/zh-CN/news/278689964.md)